Wellfuro 500 Tablet contains Cefuroxime 500 mg, a second-generation cephalosporin antibiotic with broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and Lyme disease. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Wellfuro 500 is effective against pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Staphylococcus aureus. The tablet should be administered orally, preferably after meals to enhance absorption and reduce gastrointestinal discomfort. Dosage and duration of therapy depend on the severity and type of infection, as well as patient-specific factors such as renal function. Common side effects may include gastrointestinal disturbances like nausea, diarrhea, and abdominal pain, while hypersensitivity reactions such as rash or anaphylaxis are rare but require immediate medical attention. Wellfuro 500 should be used cautiously in patients with a history of penicillin or cephalosporin allergy. It is contraindicated in individuals with known hypersensitivity to cefuroxime or other cephalosporins. Proper adherence to prescribed dosage is essential to prevent resistance development and ensure therapeutic efficacy.